Abstract
A purified thermo-tolerant lipase of Streptomyces STL-D8 was immobilized onto the natural fibres namely ‘Bombax’. Hydrolytic activity of this fibre-bound lipase was determined for hydrolysis of p-NPP in a 0.05 M Tris buffer (pH 8.5) at 55°C. This fibre-bound lipase was used to synthesize methyl succinate using methanol and succinic acid as reactants in DMSO at 55°C under shaking. Although a low yield of methyl succinate was observed in reaction mixture at 16 h (14.3 mM) yet the yield of methyl succinate was improved by optimizing molar ratio of reactants to 75 mM: 100 mM (succinic acid: methanol) in DMSO. Molecular sieves added to the reaction system at a concentration of 30 mg/2 mL increased the synthesis of methyl succinate from 30.0 mM to 31.4 mM. The volumetric scale up of the reaction system to 10 and 50 mL produced more or less a similar yield (29.1 mM to 27.9 mM) of methyl succinate after 16 h of reaction. Methyl succinate is a therapeutic molecule that has insulin sensitizing property comparable to that of glucose.
Keywords: Streptomyces sp. STL-D8, lipase, natural fibres, methyl succinate, immobilized biocatalyst, DMSO.
Graphical Abstract
Current Biotechnology
Title:Synthesis of Methyl Succinate by Natural-Fibre Immobilized Lipase of Streptomyces sp. STL-D8
Volume: 3 Issue: 2
Author(s): Ramesh Kumar, Ashok Kumar and Shamsher S. Kanwar
Affiliation:
Keywords: Streptomyces sp. STL-D8, lipase, natural fibres, methyl succinate, immobilized biocatalyst, DMSO.
Abstract: A purified thermo-tolerant lipase of Streptomyces STL-D8 was immobilized onto the natural fibres namely ‘Bombax’. Hydrolytic activity of this fibre-bound lipase was determined for hydrolysis of p-NPP in a 0.05 M Tris buffer (pH 8.5) at 55°C. This fibre-bound lipase was used to synthesize methyl succinate using methanol and succinic acid as reactants in DMSO at 55°C under shaking. Although a low yield of methyl succinate was observed in reaction mixture at 16 h (14.3 mM) yet the yield of methyl succinate was improved by optimizing molar ratio of reactants to 75 mM: 100 mM (succinic acid: methanol) in DMSO. Molecular sieves added to the reaction system at a concentration of 30 mg/2 mL increased the synthesis of methyl succinate from 30.0 mM to 31.4 mM. The volumetric scale up of the reaction system to 10 and 50 mL produced more or less a similar yield (29.1 mM to 27.9 mM) of methyl succinate after 16 h of reaction. Methyl succinate is a therapeutic molecule that has insulin sensitizing property comparable to that of glucose.
Export Options
About this article
Cite this article as:
Kumar Ramesh, Kumar Ashok and Kanwar S. Shamsher, Synthesis of Methyl Succinate by Natural-Fibre Immobilized Lipase of Streptomyces sp. STL-D8, Current Biotechnology 2014; 3 (2) . https://dx.doi.org/10.2174/2211550102666140107232547
DOI https://dx.doi.org/10.2174/2211550102666140107232547 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents on Diacylglycerol Production and Applications
Recent Patents on Chemical Engineering Therapeutic Potential of the Mammalian Pyruvate Dehydrogenase Kinases in the Prevention of Hyperglycaemia
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology Hematopoietic Transplants for Disease Suppression and Cure in Type 1 Diabetes
Current Stem Cell Research & Therapy Phospholipid Transfer Protein in Diabetes, Metabolic Syndrome and Obesity
Cardiovascular & Hematological Disorders-Drug Targets Microparticles in Health and Disease: Small Mediators, Large Role?
Current Vascular Pharmacology 2-Mercapto Benzothiazole Derivatives: As Potential Leads for the Diabetic Management
Medicinal Chemistry Therapeutic Effects of Renal Denervation on Renal Failure
Current Neurovascular Research Flavonoid Rich Fraction of Dioscorea bulbifera Linn. (Yam) Enhances Mitochondrial Enzymes and Antioxidant Status, Thereby Protects Heart from Isoproterenol Induced Myocardial Infarction
Current Pharmaceutical Biotechnology Phase 4 Studies in Heart Failure - What is Done and What is Needed?
Current Cardiology Reviews 25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Applicability, Commercial Utility and Recent Patents on Starch and Starch Derivative as Pharmaceutical Drug Delivery Carrier
Recent Patents on Drug Delivery & Formulation Pharmacological Interactions on Blood Pressure Control in Arterial Hypertension, An Issue not to be Overlooked
Cardiovascular & Hematological Disorders-Drug Targets Cord Blood as Diagnostic Window for Preeclampsia
Recent Patents on Biomarkers Apoptosis and Oxidative Stress-Related Diseases: The p66Shc Connection
Current Molecular Medicine Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases
CNS & Neurological Disorders - Drug Targets Recent Patents Relating to siRNAs and Therapeutic Strategies for Genetic Diseases
Recent Patents on DNA & Gene Sequences QSAR Studies of PTP1B Inhibitors: 1, 2-Naphthoquinone Derivatives
Letters in Drug Design & Discovery Advances in Treating the Ischaemic Diabetic Foot
Current Vascular Pharmacology The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry